loading page

Acquired Amegakaryocytic Thrombocytopenic Purpura (AAMT) Case Series and a single center experience
  • +7
  • Samah Kohla,
  • Shehab Fareed,
  • Khalid Ahmed,
  • Aliaa Amer,
  • Khaldun Obeidat,
  • Dina Soliman,
  • Reda Youssef ,
  • Mohammad Abdulla,
  • Hana Qasim,
  • Feryal Ibrahim
Samah Kohla
Hamad Medical Corporation

Corresponding Author:[email protected]

Author Profile
Shehab Fareed
Hamad Medical Corporation
Author Profile
Khalid Ahmed
Hamad Medical Corporation
Author Profile
Aliaa Amer
Hamad Medical Corporation
Author Profile
Khaldun Obeidat
John H Stroger Jr Hospital of Cook County
Author Profile
Dina Soliman
Hamad Medical Corporation
Author Profile
Reda Youssef
Hamad Medical Corporation
Author Profile
Mohammad Abdulla
Hamad Medical Corporation
Author Profile
Hana Qasim
Hamad Medical Corporation
Author Profile
Feryal Ibrahim
Hamad Medical Corporation
Author Profile

Abstract

Acquired Amegakaryocytic Thrombocytopenia is a rare hematologic condition, with <50 cases reported. It is characterized by severe thrombocytopenia with complete absence or severe reduction of megakaryocytes in the bone marrow with otherwise normal hematopoiesis. Its mechanism is not fully understood but is suggested to be related to anti-thrombopoietin antibodies.